231 related articles for article (PubMed ID: 19224751)
21. Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.
Sargent DJ; Shi Q; Gill S; Louvet C; Everson RB; Kellner U; Clancy TE; Pipas JM; Resnick MB; Meyers MO; Wu TT; Huntsman D; Validire P; Farooq U; Pavey ES; Beaudry G; Haince JF; Fradet Y
Clin Cancer Res; 2014 Aug; 20(16):4361-9. PubMed ID: 24919572
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
[TBL] [Abstract][Full Text] [Related]
23. Molecular staging of node negative patients with colorectal cancer.
Hyslop T; Waldman SA
J Cancer; 2013; 4(3):193-9. PubMed ID: 23459453
[TBL] [Abstract][Full Text] [Related]
24. Does stage II colorectal cancer need to be redefined?
Grothey A
Clin Cancer Res; 2011 May; 17(10):3053-5. PubMed ID: 21498396
[TBL] [Abstract][Full Text] [Related]
25. Expression of the intestinal biomarkers Guanylyl cyclase C and CDX2 in poorly differentiated colorectal carcinomas.
Winn B; Tavares R; Matoso A; Noble L; Fanion J; Waldman SA; Resnick MB
Hum Pathol; 2010 Jan; 41(1):123-8. PubMed ID: 19800103
[TBL] [Abstract][Full Text] [Related]
26. The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.
Wilson C; Lin JE; Li P; Snook AE; Gong J; Sato T; Liu C; Girondo MA; Rui H; Hyslop T; Waldman SA
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2328-37. PubMed ID: 25304930
[TBL] [Abstract][Full Text] [Related]
27. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.
Carrithers SL; Parkinson SJ; Goldstein SD; Park PK; Urbanski RW; Waldman SA
Dis Colon Rectum; 1996 Feb; 39(2):171-81. PubMed ID: 8620784
[TBL] [Abstract][Full Text] [Related]
28. Molecular staging individualizing cancer management.
Mejia A; Schulz S; Hyslop T; Weinberg DS; Waldman SA
J Surg Oncol; 2012 Apr; 105(5):468-74. PubMed ID: 22441898
[TBL] [Abstract][Full Text] [Related]
29. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients.
Bustin SA; Siddiqi S; Ahmed S; Hands R; Dorudi S
Int J Cancer; 2004 Jan; 108(3):412-7. PubMed ID: 14648708
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
31. Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.
Aka AA; Rappaport JA; Pattison AM; Sato T; Snook AE; Waldman SA
Expert Rev Clin Pharmacol; 2017 May; 10(5):549-557. PubMed ID: 28162021
[TBL] [Abstract][Full Text] [Related]
32. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
33. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
[TBL] [Abstract][Full Text] [Related]
34. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.
Gu CD; Osaki T; Oyama T; Inoue M; Kodate M; Dobashi K; Oka T; Yasumoto K
Ann Surg; 2002 Jan; 235(1):133-9. PubMed ID: 11753052
[TBL] [Abstract][Full Text] [Related]
35. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis.
Rahbari NN; Bork U; Motschall E; Thorlund K; Büchler MW; Koch M; Weitz J
J Clin Oncol; 2012 Jan; 30(1):60-70. PubMed ID: 22124103
[TBL] [Abstract][Full Text] [Related]
36. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
37. Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer.
Ohlsson L; Lindmark G; Israelsson A; Palmqvist R; Öberg Å; Hammarström ML; Hammarström S
Br J Cancer; 2012 Jun; 107(1):150-7. PubMed ID: 22699826
[TBL] [Abstract][Full Text] [Related]
38. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.
Nosotti M; Falleni M; Palleschi A; Pellegrini C; Alessi F; Bosari S; Santambrogio L
Chest; 2005 Sep; 128(3):1539-44. PubMed ID: 16162755
[TBL] [Abstract][Full Text] [Related]
39. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases.
Martínez-Piñeiro L; Rios E; Martínez-Gomariz M; Pastor T; de Cabo M; Picazo ML; Palacios J; Perona R
Eur Urol; 2003 Apr; 43(4):342-50. PubMed ID: 12667714
[TBL] [Abstract][Full Text] [Related]
40. CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients.
Harder J; Engelstaedter V; Usadel H; Lassmann S; Werner M; Baier P; Otto F; Varbanova M; Schaeffner E; Olschewski M; Blum HE; Opitz OG
Br J Cancer; 2009 Jan; 100(2):360-5. PubMed ID: 19142184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
